In agreement with the role played by IF1 as inhibitor of OXPHOS and stimulator of both glycolysis [15, 18] and proliferation of cancer cells [14, 18, 19] we have observed that hIF1 expression in the liver mediates the rewiring of metabolism to an enhanced glycolysis that could support the elevated proliferation rate of the carcinomas. Here, ATP5IF1 is linked to cancer.